Cover Image
Market Research Report
Product code 
1046568

Drug Screening Market by Product (Consumables, Urine Testing Devices, Analytical, Breathalyzer, Chromatography, Immunoassay) & Services, Sample Type(Urine, Breath), End User(Workplace, Laboratories, Criminal Justice, Hospitals) - Global Forecast -2026

Published: | MarketsandMarkets | 215 Pages | Delivery time: 1-2 business days

Price

Back to Top
Drug Screening Market by Product (Consumables, Urine Testing Devices, Analytical, Breathalyzer, Chromatography, Immunoassay) & Services, Sample Type(Urine, Breath), End User(Workplace, Laboratories, Criminal Justice, Hospitals) - Global Forecast -2026
Published: January 11, 2022
MarketsandMarkets
Content info: 215 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents

The global drug screening market is projected to reach USD 11.6 billion by 2026, from USD 5.3 billion in 2021, at a CAGR of 16.8% during the forecast period. Market growth can be largely attributed to the growing drug & alcohol consumption and the enforcement of stringent laws mandating drug & alcohol testing, rising regulatory approvals for drug screening products & services. On the other hand, bans on alcohol consumption in Islamic countries and prohibitions on workplace drug testing in specific countries may hinder the growth of this market to a certain extent.

"Drug screening services are expected to grow at the highest CAGR during the forecast period"

Drug screening market is segmented into products and services. In 2020,the services segment is expected to hold the largest share 57.4% of the drug screening market, growth in this segment is attributed to factors such growing drug & alcohol consumption worldwide, funding initiatives for drug testing laboratories, service launches and regulatory approvals, and geographic expansion of drug testing laboratories.

By sample type, urine samples are expected to dominate the market during the forecast period"

The drug screening market is segmented into urine, breath, hair, oral, and other samples on the basis of sample type. The urine sample segment is expected to hold the largest share 61.5% of the drug screening market in 2020 due to the benefits it offers such as easy collection method, high accuracy in the detection of multiple drugs, cost-effectiveness, and instant results.

"North America will dominate the market during the forecast period."

Geographically, the drug screening market is segmented into North America, Europe, the Asia Pacific, and Rest of the World. In 2020, North America accounted for the largest share of 48.2% of the drug screening marke tfollowed by Europe. However, Asia Pacific is expected to register the highest CAGR 19.6% during the forecast period. The high growth of this regional segment is attributed due to the growing illicit consumption of drugs, the developing healthcare infrastructure and rising adoption of stringent regulatory guidelines for drug testing.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type -Tier 1: 57%, Tier 2: 30%,and Tier 3: 13%
  • By Designation - C-level:30%, D-level:45%, and Others:25%
  • By Region - North America:40%, Europe:19%, Asia Pacific:29%, and Rest of the World: 12%

Some of the prominent players operating in the drug screening market are LabCorp (US), Quest Diagnostics (US), Abbott Laboratories (US), OraSure Technologies (US), Alfa Scientific Designs (US), Thermo Fisher Scientific (US), Dragerwerk (Germany), LifeLoc (US), MPD Inc. (US), Omega Laboratories (US), Premier Biotech (US), Psychemedics (US), Roche (Switzerland), Shimadzu (Japan), and Siemens Healthineers (Germany).

Research Coverage:

This report provides a detailed picture of the global drug screening market. It aims at estimating the size and future growth potential of the market across different segments, such as product and service, sample type, end user,and region. The report also analyzes factors (such as drivers, restraints, and opportunities) affecting the market growth. It evaluates the opportunities in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total drug screening market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on drug screening offered by the top 25 players in the drug screening market. The report analyses the drug screening market by product and service, sample type, end user, and region.
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various drug screening across key geographic regions.
  • Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the drug screening market.
  • Competitive Assessment: In-depth assessment of market ranking and strategies of the leading players in the drug screening market.
Product Code: MD 3239

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
  • 1.6 MARKET STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
    • FIGURE 2 PRIMARY SOURCES
      • 2.1.2.1 Key industry insights
      • 2.1.2.2 Breakdown of primary interviews
    • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY, DESIGNATION, AND REGION
    • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER AND REGION
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 TOTAL MARKET SIZE: DRUG SCREENING MARKET
    • FIGURE 5 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
    • FIGURE 6 BOTTOM-UP APPROACH: NO OF TESTING VOLUME BASED ESTIMATION
    • 2.2.2 TOP-DOWN APPROACH: CONTRIBUTION-BASED MARKET SIZE ESTIMATION
    • FIGURE 7 DRUG SCREENING MARKET: TOP-DOWN APPROACH
    • 2.2.3 GROWTH FORECAST
    • FIGURE 8 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN THE DRUG SCREENING MARKET (2021-2026)
    • FIGURE 9 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • 2.3 MARKET BREAKDOWN & DATA TRIANGULATION
    • FIGURE 10 DATA TRIANGULATION METHODOLOGY
  • 2.4 ASSUMPTIONS FOR THE STUDY
  • 2.5 RISK ASSESSMENT
    • TABLE 1 RISK ASSESSMENT: DRUG SCREENING MARKET
  • 2.6 LIMITATIONS

3 EXECUTIVE SUMMARY

    • FIGURE 11 DRUG SCREENING SERVICES MARKET TO RECORD THE HIGHEST CAGR DURING THE FORECAST PERIOD
    • FIGURE 12 ANALYTICAL INSTRUMENTS SEGMENT TO DOMINATE THE DRUG SCREENING PRODUCTS MARKET, 2021-2026 (USD MILLION)
    • FIGURE 13 DRUG TESTING LABORATORIES ARE EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE END-USER MARKET DURING THE FORECAST PERIOD (USD MILLION)
    • FIGURE 14 GEOGRAPHIC SNAPSHOT OF THE DRUG SCREENING MARKET

4 PREMIUM INSIGHTS

  • 4.1 DRUG SCREENING MARKET OVERVIEW
    • FIGURE 15 GROWING CONSUMPTION OF ILLICIT DRUGS AND ALCOHOL TO DRIVE MARKET GROWTH
  • 4.2 DRUG SCREENING MARKET, BY PRODUCT & SERVICE
    • FIGURE 16 SERVICES SEGMENT TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD (USD MILLION)
  • 4.3 DRUG SCREENING MARKET, BY SAMPLE TYPE
    • FIGURE 17 ORAL FLUID SAMPLES SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD (USD MILLION)
  • 4.4 DRUG SCREENING MARKET: GEOGRAPHIC SNAPSHOT
    • FIGURE 18 INDIA TO WITNESS THE HIGHEST GROWTH RATE IN THE DRUG SCREENING MARKET DURING THE FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 19 DRUG SCREENING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Growing drug & alcohol consumption
      • 5.2.1.2 Enforcement of stringent laws mandating drug & alcohol testing
      • 5.2.1.3 Rising regulatory approvals for drug screening products & services
    • TABLE 2 KEY PRODUCT & SERVICE LAUNCHES (2018-2021)
    • TABLE 3 RECENT APPROVALS FOR DRUG & ALCOHOL TESTING PRODUCTS & SERVICES
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Ban on alcohol consumption in several Islamic countries
      • 5.2.2.2 Prohibition on workplace drug testing in specific countries
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Oral fluid testing
      • 5.2.3.2 Fingerprint-based drug testing
      • 5.2.3.3 Emerging economies
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Accuracy and specificity concerns related to breathalyzers
  • 5.3 VALUE CHAIN ANALYSIS
    • FIGURE 20 DRUG SCREENING MARKET: VALUE CHAIN ANALYSIS
  • 5.4 ECOSYSTEM ANALYSIS
    • FIGURE 21 ECOSYSTEM: DRUG SCREENING MARKET
    • TABLE 4 ROLE OF MARKET PLAYERS IN THE DRUG SCREENING ECOSYSTEM
  • 5.5 IMPACT OF COVID 19 ON DRUG SCREENING MARKET
  • 5.6 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 5 DRUG SCREENING MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.6.1 DEGREE OF COMPETITION
    • 5.6.2 BARGAINING POWER OF SUPPLIERS
    • 5.6.3 BARGAINING POWER OF BUYERS
    • 5.6.4 THREAT OF SUBSTITUTES
    • 5.6.5 THREAT OF NEW ENTRANTS
  • 5.7 TECHNOLOGY ANALYSIS
  • 5.8 REGULATORY ANALYSIS
    • 5.8.1 REGULATORY ASPECTS OF WORKPLACE DRUG TESTING
      • 5.8.1.1 US
        • 5.8.1.1.1 Substance Abuse and Mental Health Services Administration (SAMSHA)
          • 5.8.1.1.1.1 Federal workplace drug testing
          • 5.8.1.1.1.2 Federal laws and regulations
        • 5.8.1.1.2 Department of Transportation (DOT)
    • TABLE 6 US: DRUG AND ALCOHOL TESTING REGULATIONS
      • 5.8.1.2 Europe
        • 5.8.1.2.1 Finland
        • 5.8.1.2.2 Sweden
        • 5.8.1.2.3 France
        • 5.8.1.2.4 Italy
        • 5.8.1.2.5 United Kingdom
        • 5.8.1.2.6 Netherlands
        • 5.8.1.2.7 Ireland
      • 5.8.1.3 Australia and New Zealand
  • 5.9 PATENT ANALYSIS
  • 5.10 CASE STUDY ANALYSIS
    • 5.10.1 LEADING RETAIL CHAIN SAVES $1 MILLION WITH INSTANT ORAL FLUID EMPLOYEE DRUG SCREEN SOLUTION
    • 5.10.2 A BETTER AND INCREASINGLY EFFICIENT DRUG SCREENING SYSTEM
    • 5.10.3 PRE-EMPLOYMENT TESTING-LONG TERM CARE INDUSTRY
    • 5.10.4 HAIR TESTING VS. URINALYSIS (TRANSPORTATION INDUSTRY)
    • 5.10.5 RANDOM TESTING (MANUFACTURING/AUTOMOTIVE)
    • 5.10.6 CONTRACTOR TESTING (OIL/GAS)
    • 5.10.7 KINGS TRANSPORT-DRUG AND ALCOHOL TESTING

6 DRUG SCREENING MARKET, BY PRODUCT & SERVICE

  • 6.1 INTRODUCTION
    • TABLE 7 DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
  • 6.2 DRUG SCREENING SERVICES
    • 6.2.1 ADVANCED DRUG SCREENING TESTS & SERVICES TO DRIVE THE GROWTH OF THIS SEGMENT
    • TABLE 8 DRUG SCREENING SERVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 6.3 DRUG SCREENING PRODUCTS
    • TABLE 9 DRUG SCREENING PRODUCT MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • 6.3.1 ANALYTICAL INSTRUMENTS
    • TABLE 10 DRUG SCREENING PRODUCT MARKET FOR ANALYTICAL INSTRUMENTS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 11 DRUG SCREENING PRODUCTS MARKET FOR ANALYTICAL INSTRUMENTS, BY REGION, 2019-2026 (USD MILLION)
      • 6.3.1.1 Breathalyzers
        • 6.3.1.1.1 Law enforcement agencies widely use breathalyzers
    • TABLE 12 BREATHALYZERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 13 BREATHALYZERS MARKET, BY REGION, 2019-2026 (USD MILLION)
        • 6.3.1.1.2 Fuel-cell breathalyzers
    • TABLE 14 FUEL-CELL BREATHALYZERS MARKET, BY REGION, 2019-2026 (USD MILLION)
        • 6.3.1.1.3 Semiconductor breathalyzers
    • TABLE 15 SEMICONDUCTOR BREATHALYZERS MARKET, BY REGION, 2019-2026 (USD MILLION)
        • 6.3.1.1.4 Other breathalyzers
    • TABLE 16 OTHER BREATHALYZERS MARKET, BY REGION, 2019-2026 (USD MILLION)
      • 6.3.1.2 Immunoassay analyzers
        • 6.3.1.2.1 North America is the largest market for immunoassay analyzers
    • TABLE 17 IMMUNOASSAY ANALYZERS MARKET, BY REGION, 2019-2026 (USD MILLION)
      • 6.3.1.3 Chromatography instruments
        • 6.3.1.3.1 Chromatography techniques show higher accuracy than immunoassays
    • TABLE 18 CHROMATOGRAPHY INSTRUMENTS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 6.3.2 RAPID TESTING DEVICES
    • TABLE 19 DRUG SCREENING PRODUCT MARKET FOR RAPID TESTING DEVICES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 20 DRUG SCREENING PRODUCT MARKET FOR RAPID TESTING DEVICES, BY REGION, 2019-2026 (USD MILLION)
      • 6.3.2.1 Urine testing devices
        • 6.3.2.1.1 Urine testing provides results within minutes and is used in a wide range of applications
    • TABLE 21 URINE TESTING DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 22 URINE TESTING DEVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
        • 6.3.2.1.2 Drug testing cups
    • TABLE 23 DRUG TESTING CUPS MARKET, BY REGION, 2019-2026 (USD MILLION)
        • 6.3.2.1.3 Dip cards
    • TABLE 24 DIP CARDS MARKET, BY REGION, 2019-2026 (USD MILLION)
        • 6.3.2.1.4 Drug testing cassettes
    • TABLE 25 DRUG TESTING CASSETTES MARKET, BY REGION, 2019-2026 (USD MILLION)
      • 6.3.2.2 Oral fluid testing devices
        • 6.3.2.2.1 Short detection windows, noninvasive nature, and low chance of sample tampering ensures the demand for oral fluid testing
    • TABLE 26 ORAL FLUID TESTING DEVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 6.3.3 CONSUMABLES
    • TABLE 27 DRUG SCREENING CONSUMABLES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 28 DRUG SCREENING CONSUMABLES MARKET, BY REGION, 2019-2026 (USD MILLION)
      • 6.3.3.1 Assay kits
        • 6.3.3.1.1 Immunoassay kits provide a rapid and inexpensive method to screen samples
    • TABLE 29 ASSAY KITS MARKET, BY REGION, 2019-2026 (USD MILLION)
      • 6.3.3.2 Sample collection devices
        • 6.3.3.2.1 Sample collection devices see wide usage in drug testing laboratories
    • TABLE 30 SAMPLE COLLECTION DEVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
      • 6.3.3.3 Calibrators & controls
    • TABLE 31 CALIBRATORS & CONTROLS MARKET, BY REGION, 2019-2026 (USD MILLION)
      • 6.3.3.4 Other consumables
    • TABLE 32 OTHER CONSUMABLES MARKET, BY REGION, 2019-2026 (USD MILLION)

7 DRUG SCREENING MARKET, BY SAMPLE TYPE

  • 7.1 INTRODUCTION
    • TABLE 33 DRUG SCREENING MARKET, BY SAMPLE TYPE, 2019-2026 (USD MILLION)
  • 7.2 URINE SAMPLES
    • 7.2.1 EASE OF COLLECTION AND NONINVASIVENESS HAS SUPPORTED THE USE OF URINE SAMPLES
    • TABLE 34 DRUG SCREENING MARKET FOR URINE SAMPLES, BY REGION, 2019-2026 (USD MILLION)
  • 7.3 BREATH SAMPLES
    • 7.3.1 BREATH ALCOHOL TESTS SEE WIDE USAGE IN WORKPLACE TESTING AND LAW ENFORCEMENT APPLICATIONS
    • TABLE 35 DRUG SCREENING MARKET FOR BREATH SAMPLES, BY REGION, 2019-2026 (USD MILLION)
  • 7.4 ORAL FLUID SAMPLES
    • 7.4.1 NONINVASIVE SAMPLE COLLECTION AND LOW CHANCE OF ADULTERATION HAVE SUPPORTED THE USAGE OF ORAL FLUID SAMPLES
    • TABLE 36 DRUG SCREENING MARKET FOR ORAL FLUID SAMPLES, BY REGION, 2019-2026 (USD MILLION)
  • 7.5 HAIR SAMPLES
    • 7.5.1 HAIR SAMPLES CAN PROVIDE INSIGHTS INTO LONG-TERM DRUG USE
    • TABLE 37 DRUG SCREENING MARKET FOR HAIR SAMPLES, BY REGION, 2019-2026 (USD MILLION)
  • 7.6 OTHER SAMPLES
    • TABLE 38 DRUG SCREENING MARKET FOR OTHER SAMPLES, BY REGION, 2019-2026 (USD MILLION)

8 DRUG SCREENING MARKET, BY END USER

  • 8.1 INTRODUCTION
    • TABLE 39 DRUG SCREENING MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 8.2 DRUG TESTING LABORATORIES
    • 8.2.1 DRUG TESTING LABORATORIES TO EXHIBIT THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
    • TABLE 40 DRUG SCREENING MARKET FOR DRUG TESTING LABORATORIES, BY REGION, 2019-2026 (USD MILLION)
  • 8.3 WORKPLACES
    • 8.3.1 THE RISING NUMBER OF DRUG ABUSE CASES HAS RESULTED IN AN INCREASE IN WORKPLACE TESTING
    • TABLE 41 DRUG SCREENING MARKET FOR WORKPLACES, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 42 US: DRUG SCREENING MARKET, BY WORKPLACE TYPE, 2019-2026 (USD MILLION)
  • 8.4 CRIMINAL JUSTICE SYSTEMS & LAW ENFORCEMENT AGENCIES
    • 8.4.1 URINE IS THE MOST COMMONLY USED SAMPLE IN CRIMINAL JUSTICE SYSTEMS
    • TABLE 43 DRUG SCREENING MARKET FOR CRIMINAL JUSTICE SYSTEMS & LAW ENFORCEMENT AGENCIES, BY REGION, 2019-2026 (USD MILLION)
  • 8.5 HOSPITALS
    • 8.5.1 RISING INCIDENCE OF DRUG ABUSE HAS RESULTED IN AN INCREASE IN EMERGENCY DEPARTMENT VISITS
    • TABLE 44 DRUG SCREENING MARKET FOR HOSPITALS, BY REGION, 2019-2026 (USD MILLION)
  • 8.6 DRUG TREATMENT CENTERS
    • 8.6.1 AVAILABILITY OF GOVERNMENT SUPPORT IS A KEY GROWTH DRIVER FOR REHABILITATION CENTERS
    • TABLE 45 DRUG SCREENING MARKET FOR DRUG TREATMENT CENTERS, BY REGION, 2019-2026 (USD MILLION)
  • 8.7 INDIVIDUAL USERS
    • 8.7.1 PERSONAL BREATHALYZERS ARE WITNESSING INCREASING ADOPTION DUE TO STRINGENT DUI REGULATIONS
    • TABLE 46 DRUG SCREENING MARKET FOR INDIVIDUAL USERS, BY REGION, 2019-2026 (USD MILLION)
  • 8.8 PAIN MANAGEMENT CENTERS
    • 8.8.1 RISING SUBSTANCE ABUSE HAS SUPPORTED DRUG TESTING IN PAIN MANAGEMENT APPLICATIONS
    • TABLE 47 DRUG SCREENING MARKET FOR PAIN MANAGEMENT CENTERS, BY REGION, 2019-2026 (USD MILLION)
  • 8.9 SCHOOLS AND COLLEGES
    • 8.9.1 DRUG ABUSE TESTING PROGRAMS HAVE BEEN INTRODUCED IN SCHOOLS TO CURB DRUG ABUSE
    • TABLE 48 DRUG SCREENING MARKET FOR SCHOOLS AND COLLEGES, BY REGION, 2019-2026 (USD MILLION)

9 DRUG SCREENING MARKET, BY REGION

  • 9.1 INTRODUCTION
    • TABLE 49 DRUG SCREENING MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 9.2 NORTH AMERICA
    • FIGURE 22 NORTH AMERICA: DRUG SCREENING MARKET SNAPSHOT
    • TABLE 50 NORTH AMERICA: DRUG SCREENING MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 51 NORTH AMERICA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 52 NORTH AMERICA: DRUG SCREENING PRODUCT MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 53 NORTH AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 54 NORTH AMERICA: BREATHALYZERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 55 NORTH AMERICA: RAPID TESTING DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 56 NORTH AMERICA: URINE TESTING DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 57 NORTH AMERICA: CONSUMABLES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 58 NORTH AMERICA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2019-2026 (USD MILLION)
    • TABLE 59 NORTH AMERICA: DRUG SCREENING MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.2.1 US
      • 9.2.1.1 The US holds the largest share of the drug screening market in North America
    • TABLE 60 US: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 61 US: DRUG SCREENING PRODUCT MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 62 US: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 63 US: BREATHALYZERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 64 US: RAPID TESTING DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 65 US: URINE TESTING DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 66 US: CONSUMABLES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 67 US: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2019-2026 (USD MILLION)
    • TABLE 68 US: DRUG SCREENING MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.2.2 CANADA
      • 9.2.2.1 The high rate of DUI-related accidental deaths is expected to drive the use of breathalyzers in this market
    • TABLE 69 CANADA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 70 CANADA: DRUG SCREENING PRODUCT MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 71 CANADA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 72 CANADA: BREATHALYZERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 73 CANADA: RAPID TESTING DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 74 CANADA: URINE TESTING DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 75 CANADA: CONSUMABLES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 76 CANADA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2019-2026 (USD MILLION)
    • TABLE 77 CANADA: DRUG SCREENING MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 9.3 EUROPE
    • TABLE 78 EUROPE: DRUG SCREENING MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 79 EUROPE: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 80 EUROPE: DRUG SCREENING PRODUCT MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 81 EUROPE: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 82 EUROPE: BREATHALYZERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 83 EUROPE: RAPID TESTING DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 84 EUROPE: URINE TESTING DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 85 EUROPE: CONSUMABLES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 86 EUROPE: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2019-2026 (USD MILLION)
    • TABLE 87 EUROPE: DRUG SCREENING MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.3.1 GERMANY
      • 9.3.1.1 The rising number of drug-related deaths in Germany drives the demand for drug screening products & services
    • TABLE 88 GERMANY: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 89 GERMANY: DRUG SCREENING PRODUCT MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 90 GERMANY: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 91 GERMANY: BREATHALYZERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 92 GERMANY: RAPID TESTING DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 93 GERMANY: URINE TESTING DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 94 GERMANY: CONSUMABLES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 95 GERMANY: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2019-2026 (USD MILLION)
    • TABLE 96 GERMANY: DRUG SCREENING MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.3.2 FRANCE
      • 9.3.2.1 Cannabis and cocaine are the most widely used illicit substances in France
    • TABLE 97 FRANCE: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 98 FRANCE: DRUG SCREENING PRODUCT MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 99 FRANCE: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 100 FRANCE: BREATHALYZERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 101 FRANCE: RAPID TESTING DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 102 FRANCE: URINE TESTING DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 103 FRANCE: CONSUMABLES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 104 FRANCE: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2019-2026 (USD MILLION)
    • TABLE 105 FRANCE: DRUG SCREENING MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.3.3 UK
      • 9.3.3.1 Favorable government support is a key growth driver for the UK market
    • TABLE 106 UK: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 107 UK: DRUG SCREENING PRODUCT MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 108 UK: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 109 UK: BREATHALYZERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 110 UK: RAPID TESTING DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 111 UK: URINE TESTING DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 112 UK: CONSUMABLES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 113 UK: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2019-2026 (USD MILLION)
    • TABLE 114 UK: DRUG SCREENING MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.3.4 ITALY
      • 9.3.4.1 Cannabis is the most widely used illicit drug among adolescents in Italy
    • TABLE 115 ITALY: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 116 ITALY: DRUG SCREENING PRODUCT MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 117 ITALY: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 118 ITALY: RAPID TESTING DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 119 ITALY: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2019-2026 (USD MILLION)
    • TABLE 120 ITALY: DRUG SCREENING MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.3.5 SPAIN
      • 9.3.5.1 Cannabis and cocaine are the most widely used drugs in Spain among adolescents and adults
    • TABLE 121 SPAIN: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 122 SPAIN: DRUG SCREENING PRODUCT MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 123 SPAIN: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 124 SPAIN: RAPID TESTING DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 125 SPAIN: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2019-2026 (USD MILLION)
    • TABLE 126 SPAIN: DRUG SCREENING MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.3.6 ROE
    • TABLE 127 ROE: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 128 ROE: DRUG SCREENING PRODUCT MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 129 ROE: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 130 ROE: BREATHALYZERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 131 ROE: RAPID TESTING DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 132 ROE: URINE TESTING DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 133 ROE: CONSUMABLES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 134 ROE: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2019-2026 (USD MILLION)
    • TABLE 135 ROE: DRUG SCREENING MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 9.4 ASIA PACIFIC (APAC)
    • FIGURE 23 APAC: DRUG SCREENING MARKET SNAPSHOT
    • TABLE 136 APAC: DRUG SCREENING MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 137 APAC: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 138 APAC: DRUG SCREENING PRODUCT MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 139 APAC: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 140 APAC: BREATHALYZERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 141 APAC: RAPID TESTING DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 142 APAC: URINE TESTING DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 143 APAC: CONSUMABLES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 144 APAC: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2019-2026 (USD MILLION)
    • TABLE 145 APAC: DRUG SCREENING MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.4.1 CHINA
      • 9.4.1.1 China accounted for the largest share of the drug screening market in the APAC region in 2020
    • TABLE 146 CHINA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 147 CHINA: DRUG SCREENING PRODUCT MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 148 CHINA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 149 CHINA: BREATHALYZERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 150 CHINA: RAPID TESTING DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 151 CHINA: URINE TESTING DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 152 CHINA: CONSUMABLES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 153 CHINA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2019-2026 (USD MILLION)
    • TABLE 154 CHINA: DRUG SCREENING MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.4.2 JAPAN
      • 9.4.2.1 Stringent laws for drug abuse and the growing awareness of drug addiction are key growth drivers in Japan
    • TABLE 155 JAPAN: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 156 JAPAN: DRUG SCREENING PRODUCT MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 157 JAPAN: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 158 JAPAN: BREATHALYZERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 159 JAPAN: RAPID TESTING DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 160 JAPAN: URINE TESTING DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 161 JAPAN: CONSUMABLES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 162 JAPAN: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2019-2026 (USD MILLION)
    • TABLE 163 JAPAN: DRUG SCREENING MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.4.3 INDIA
      • 9.4.3.1 The increasing burden of DUI-road cases in the country to drive the growth of the drug screening market
    • TABLE 164 INDIA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 165 INDIA: DRUG SCREENING PRODUCT MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 166 INDIA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 167 INDIA: BREATHALYZERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 168 INDIA: RAPID TESTING DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 169 INDIA: URINE TESTING DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 170 INDIA: CONSUMABLES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 171 INDIA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2019-2026 (USD MILLION)
    • TABLE 172 INDIA: DRUG SCREENING MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.4.4 REST OF ASIA PACIFIC (ROAPAC)
    • TABLE 173 ROAPAC: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 174 ROAPAC: DRUG SCREENING PRODUCT MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 175 ROAPAC: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 176 ROAPAC: BREATHALYZERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 177 ROAPAC: RAPID TESTING DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 178 ROAPAC: URINE TESTING DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 179 ROAPAC: CONSUMABLES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 180 ROAPAC: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2019-2026 (USD MILLION)
    • TABLE 181 ROAPAC: DRUG SCREENING MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 9.5 REST OF THE WORLD (ROW)
    • TABLE 182 ROW: DRUG SCREENING MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 183 ROW: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 184 ROW: DRUG SCREENING PRODUCT MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 185 ROW: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 186 ROW: BREATHALYZERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 187 ROW: RAPID TESTING DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 188 ROW: URINE TESTING DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 189 ROW: CONSUMABLES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 190 ROW: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2019-2026 (USD MILLION)
    • TABLE 191 ROW: DRUG SCREENING MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.5.1 LATAM
      • 9.5.1.1 Increasing incidence of drug overdose and favorable government support are key growth drivers in this region
    • TABLE 192 LATAM: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 193 LATAM: DRUG SCREENING PRODUCT MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 194 LATAM: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 195 LATAM: BREATHALYZERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 196 LATAM: RAPID TESTING DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 197 LATAM: URINE TESTING DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 198 LATAM: CONSUMABLES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 199 LATAM: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2019-2026 (USD MILLION)
    • TABLE 200 LATAM: DRUG SCREENING MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.5.2 MIDDLE EAST & AFRICA
      • 9.5.2.1 Rising drug abuse and growing emphasis on drug abuse testing supports the market growth in the MEA region
    • TABLE 201 MEA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 202 MEA: DRUG SCREENING PRODUCT MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 203 MEA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 204 MEA: BREATHALYZERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 205 MEA: RAPID TESTING DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 206 MEA: URINE TESTING DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 207 MEA: CONSUMABLES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 208 MEA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2019-2026 (USD MILLION)
    • TABLE 209 MEA: DRUG SCREENING MARKET, BY END USER, 2019-2026 (USD MILLION)

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
    • FIGURE 24 KEY DEVELOPMENTS OF PROMINENT PLAYERS OPERATING IN THE DRUG SCREENING MARKET (2018-2021)
  • 10.2 MARKET RANKING
    • FIGURE 25 DRUG SCREENING SERVICES MARKET RANKING, BY KEY PLAYER, 2020
    • FIGURE 26 RAPID TESTING DEVICES MARKET RANKING, BY KEY PLAYER, 2020
  • 10.3 COMPANY EVALUATION QUADRANT
    • 10.3.1 STARS
    • 10.3.2 EMERGING LEADERS
    • 10.3.3 PERVASIVE PLAYERS
    • 10.3.4 PARTICIPANTS
    • FIGURE 27 DRUG SCREENING MARKET: COMPANY EVALUATION QUADRANT, 2020 (OVERALL MARKET)
  • 10.4 COMPANY EVALUATION QUADRANT FOR EMERGING PLAYERS
    • 10.4.1 PROGRESSIVE COMPANIES
    • 10.4.2 STARTING BLOCKS
    • 10.4.3 RESPONSIVE COMPANIES
    • 10.4.4 DYNAMIC COMPANIES
    • FIGURE 28 DRUG SCREENING MARKET: COMPANY EVALUATION QUADRANT, 2020 (EMERGING PLAYERS)
  • 10.5 COMPETITIVE BENCHMARKING
    • 10.5.1 OVERALL COMPANY FOOTPRINT
    • TABLE 210 OVERALL COMPANY FOOTPRINT
    • 10.5.2 COMPANY PRODUCT AND SERVICE FOOTPRINT
    • TABLE 211 COMPANY PRODUCT AND SERVICE FOOTPRINT
    • 10.5.3 COMPANY PRODUCTS FOOTPRINT
    • TABLE 212 COMPANY PRODUCT FOOTPRINT
    • 10.5.4 COMPANY REGION FOOTPRINT
    • TABLE 213 COMPANY REGION FOOTPRINT
  • 10.6 COMPETITIVE SCENARIO
    • TABLE 214 PRODUCT LAUNCHES & APPROVALS (JANUARY 2018 -JUNE2021)
    • TABLE 215 DEALS (JANUARY 2018-AUGUST 2021)
    • TABLE 216 OTHER DEVELOPMENTS (JANUARY 2018- JUNE 2021)

11 COMPANY PROFILES

  • 11.1 KEY PLAYERS
  • (Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)**
    • 11.1.1 LABCORP
    • TABLE 217 LABCORP: BUSINESS OVERVIEW
    • FIGURE 29 LABCORP: COMPANY SNAPSHOT (2020)
    • 11.1.2 QUEST DIAGNOSTICS
    • TABLE 218 QUEST DIAGNOSTICS: BUSINESS OVERVIEW
    • FIGURE 30 QUEST DIAGNOSTICS: COMPANY SNAPSHOT (2020)
    • 11.1.3 ABBOTT LABORATORIES
    • TABLE 219 ABBOTT LABORATORIES: BUSINESS OVERVIEW
    • FIGURE 31 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2020)
    • 11.1.4 ORASURE TECHNOLOGIES
    • TABLE 220 ORASURE TECHNOLOGIES: BUSINESS OVERVIEW
    • FIGURE 32 ORASURE TECHNOLOGIES: COMPANY SNAPSHOTS (2020)
    • 11.1.5 ALFA SCIENTIFIC DESIGNS
    • TABLE 221 ALFA SCIENTIFIC DESIGNS: BUSINESS OVERVIEW
    • 11.1.6 THERMO FISHER SCIENTIFIC
    • TABLE 222 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW
    • FIGURE 33 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOTS (2020)
    • 11.1.7 DRAGERWERK
    • TABLE 223 DRAGERWERK: BUSINESS OVERVIEW
    • FIGURE 34 DRAGERWERK: COMPANY SNAPSHOT (2020)
    • 11.1.8 LIFELOC TECHNOLOGIES
    • TABLE 224 LIFELOC TECHNOLOGIES: BUSINESS OVERVIEW
    • FIGURE 35 LIFELOC: COMPANY SNAPSHOT (2020)
    • 11.1.9 MPD INC.
    • TABLE 225 MPD INC: BUSINESS OVERVIEW
    • 11.1.10 OMEGA LABORATORIES
    • TABLE 226 OMEGA LABORATORIES: BUSINESS OVERVIEW
    • 11.1.11 PREMIER BIOTECH
    • TABLE 227 PREMIER BIOTECH: BUSINESS OVERVIEW
    • 11.1.12 PSYCHEMEDICS
    • TABLE 228 PSYCHEMEDICS: BUSINESS OVERVIEW
    • FIGURE 36 PSYCHEMEDICS: COMPANY SNAPSHOT (2020)
  • *Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
  • 11.2 OTHER PLAYERS
    • 11.2.1 ROCHE
    • 11.2.2 SHIMADZU
    • 11.2.3 SIEMENS HEALTHINEERS
    • 11.2.4 AMERICAN BIO MEDICA CORPORATION
    • 11.2.5 ACM GLOBAL LABORATORIES
    • 11.2.6 CAREHEALTH AMERICA CORP
    • 11.2.7 CLINICAL REFERENCE LABORATORY
    • 11.2.8 INTOXIMETERS
    • 11.2.9 SCITECK, INC.
    • 11.2.10 ACCUSOURCE
    • 11.2.11 CORDANT HEALTH SOLUTIONS
    • 11.2.12 SYNENS
    • 11.2.13 MILLENNIUM HEALTH

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 AVAILABLE CUSTOMIZATIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS